Search

Search Constraints

You searched for: Author/Creator Mathijssen, Ron H. J.

Search Results

1. 4β‐hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes. (12th August 2015)

2. A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients. Issue 1 (19th July 2019)

4. AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel. Issue 8 (28th June 2019)

5. CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab. Issue 1 (8th June 2019)

7. Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study. Issue 1 (4th May 2022)

8. Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment. Issue 1 (12th July 2019)

9. Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial. Issue 2 (31st October 2021)

10. Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer. Issue 1 (26th May 2020)